• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

EFPIA Backs Greek Drug Export Ban to Avert "Humanitarian Crisis"

Article

July 16, 2015.

Reuters reports that Greece has banned the export of 25 types of drugs following warnings of shortages.

According to the Greek drug regulator, the National Organization for Medicines (EOF), there has been a significant increase in some imported medicines being shipped back out of the country.

The European Federation of Pharmaceutical Industries and Associations (EFPIA), has backed the Greek move, saying that a "proportionate, legislative ban on exporting medicines intended for Greek patients from Greece would be an appropriate and justifiable response to possible shortages and help to avert a potential humanitarian crisis."

Read Pharm Exec's Brussels correspondent Reflector's take on the Greek crisis and its implications for pharma here.

Related Videos
Related Content
UniDoc

UniDoc Brings AI-Powered Health Cube to Alaska

April 17th 2024
Article

The Health Cube will increase remote and virtual care options for populations living in remote areas.

Riccardo Butta

At-Home Patients and AI: Q&A with Riccardo Butta

April 16th 2024
Article

Butta discusses how new technologies are being implemented in at-home devices.

Say Hello to Flexible: Reimagining the Patient Journey

Say Hello to Flexible: Reimagining the Patient Journey

April 15th 2024
Article

Through embracing connected and tech-enabled services and devices, new avenues and opportunities exist for greater clinical trial flexibility in drug research.

Stock.adobe.com

ArisGlobal Announces Second Life Sciences Generative AI Council Session

April 11th 2024
Article

The meeting is scheduled for May in Switzerland.

Image credit: ArtemisDiana | stock.adobe.com

Precision Medicine: Investments and Outcomes Expected

March 18th 2024
Article

Precision medicine is now seen as a healthcare approach for both the present and the future, particularly with the explosion of personalized care delivery.

Dan Milczarski, Executive Vice President of Process and Technology, CQfluency.

All in on AI is Not the Solution in Life Sciences and Health Care

March 13th 2024
Article

Although life science organizations are not immune to the benefits of artificial intelligence, it’s important to integrate it with caution because there is no “one-size fits all” approach.